Skip to content

Biomechanical Evaluation of a Novel, Compliant Low Profile Prosthetic Foot

Biomechanical Evaluation of a Novel, Compliant Low Profile Prosthetic Foot

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06468059
Enrollment
6
Registered
2024-06-21
Start date
2024-03-21
Completion date
2024-07-16
Last updated
2025-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amputation

Brief summary

The investigators have developed a novel layered low-profile prosthetic foot that is able to provide enhanced compliance without sacrificing strength for individuals with transtibial amputation who have long residual limbs. It is hypothesized that the proposed prosthesis will offer similar benefits to these individuals as comparable higher profile prostheses offer users with shorter residual limbs. The primary goal of this Phase I proposal is to assess the degree to which the proposed prosthesis can provide benefits to prosthesis users in this population, along with characterizing the degree to which the novel prosthesis emulates its taller counterparts.

Interventions

DEVICELayered Low Profile Foot

The layered LPF is a novel low-profile prosthetic foot that provides compliant behavior while simultaneously exhibiting high mechanical strength.

DEVICEPrescribed Ankle

The prescribed ankle is the prosthetic ankle that the subject wears for daily use.

Sponsors

Kennesaw State University
CollaboratorOTHER
Little Room Innovations, LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Masking description

The control prosthesis and the experimental prosthesis are covered by a sock to prevent the participant from knowing which has been fit.

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

1. 18-89 years old 2. unilateral transtibial amputation 3. daily use of a low profile foot 4. cognitive ability to understand and willingness to provide informed consent and follow the study protocol

Exclusion criteria

1. unable to perform walking for 2 minutes without an assistive device 2. other health conditions which may prevent them from participating in the study

Design outcomes

Primary

MeasureTime frameDescription
Total Energy Stored (TES)through study completion, an average of 1 dayTES is the amount of energy absorbed by the ankle joint during early and middle stance. It is the integral of the product of joint torque and angular velocity, as determined through inverse dynamics.

Secondary

MeasureTime frameDescription
Ankle Quasi-Stiffness (AQS)through study completion, an average of 1 dayAQS is a measure of joint deformation under an applied load. It is extracted from the torque-angle relationship during walking determined through inverse dynamics. The ideal AQS varies from person to person, but in this study we were interested in seeing if the prostheses could achiever lower AQS.
Walking Speedthrough study completion, an average of 1 dayThis is the linear rate of change of position when a person walks, typically given in m/s.
Likert Scale Rating of Device Satisfactionthrough study completion, an average of 1 dayA 1 to 10 rating of device satisfaction where the pre-trial perceived device satisfaction of the participant's prescribed ankle is defined as a 5 out of 10. 1 is defined as completely unacceptable, and 10 is defined as ideal performance.

Countries

United States

Participant flow

Recruitment details

6 subjects were enrolled between 3/21/2024 and 7/16/2024 at Kennesaw State University.

Pre-assignment details

6 of 6 patients completed this crossover study.

Participants by arm

ArmCount
Layered Low Profile Foot (LPF) vs. Prescribed Ankle
In this arm, subjects will first test the LPF and then complete the tests with their prescribed ankle. Layered Low Profile Foot: The layered LPF is a novel low-profile prosthetic foot that provides compliant behavior while simultaneously exhibiting high mechanical strength. Prescribed Ankle: The prescribed ankle is the prosthetic ankle that the subject wears for daily use.
3
Prescribed Ankle vs. Layered Low Profile Foot (LPF)
In this arm, subjects will first complete the tests with their prescribed ankle and then test the LPF. Layered Low Profile Foot: The layered LPF is a novel low-profile prosthetic foot that provides compliant behavior while simultaneously exhibiting high mechanical strength. Prescribed Ankle: The prescribed ankle is the prosthetic ankle that the subject wears for daily use.
3
Total6

Baseline characteristics

CharacteristicLayered Low Profile Foot (LPF) vs. Prescribed AnklePrescribed Ankle vs. Layered Low Profile Foot (LPF)Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
3 Participants3 Participants6 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants1 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
3 Participants2 Participants5 Participants
Region of Enrollment
United States
3 participants3 participants6 participants
Sex: Female, Male
Female
0 Participants1 Participants1 Participants
Sex: Female, Male
Male
3 Participants2 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 60 / 6
other
Total, other adverse events
0 / 60 / 6
serious
Total, serious adverse events
0 / 60 / 6

Outcome results

Primary

Total Energy Stored (TES)

TES is the amount of energy absorbed by the ankle joint during early and middle stance. It is the integral of the product of joint torque and angular velocity, as determined through inverse dynamics.

Time frame: through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Prescribed AnkleTotal Energy Stored (TES)20.1 JoulesStandard Deviation 11.2
Layered Low Profile Foot (LPF)Total Energy Stored (TES)13.3 JoulesStandard Deviation 6.9
Secondary

Ankle Quasi-Stiffness (AQS)

AQS is a measure of joint deformation under an applied load. It is extracted from the torque-angle relationship during walking determined through inverse dynamics. The ideal AQS varies from person to person, but in this study we were interested in seeing if the prostheses could achiever lower AQS.

Time frame: through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Prescribed AnkleAnkle Quasi-Stiffness (AQS)9.8 Newton meters per degreeStandard Deviation 2.7
Layered Low Profile Foot (LPF)Ankle Quasi-Stiffness (AQS)9.3 Newton meters per degreeStandard Deviation 3.9
Secondary

Likert Scale Rating of Device Satisfaction

A 1 to 10 rating of device satisfaction where the pre-trial perceived device satisfaction of the participant's prescribed ankle is defined as a 5 out of 10. 1 is defined as completely unacceptable, and 10 is defined as ideal performance.

Time frame: through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Prescribed AnkleLikert Scale Rating of Device Satisfaction4.3 units on a scaleStandard Deviation 1.5
Layered Low Profile Foot (LPF)Likert Scale Rating of Device Satisfaction5.2 units on a scaleStandard Deviation 1.5
Secondary

Walking Speed

This is the linear rate of change of position when a person walks, typically given in m/s.

Time frame: through study completion, an average of 1 day

ArmMeasureValue (MEAN)Dispersion
Prescribed AnkleWalking Speed1.27 Meters per secondStandard Deviation 0.2
Layered Low Profile Foot (LPF)Walking Speed1.28 Meters per secondStandard Deviation 0.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026